AI assistant
Sending…
PRECISION BIOSCIENCES INC — Director's Dealing 2019
Jul 8, 2019
34491_dirs_2019-07-08_4eff0284-0fe7-46e6-9631-585200d3ad09.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2019-07-04
Reporting Person: Scimeca Dario (General Counsel)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-07-04 | Stock Option (Right to Buy) | $13.39 | A | 160000 | Acquired | 2029-07-03 | Common Stock (160000) | Direct |
Footnotes
F1: The option vests as to 25% of the underlying shares on June 10, 2020 and as to 6.25% of the underlying shares at the end of each successive three-month period until June 10, 2023.
More from PRECISION BIOSCIENCES INC
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 26
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8
Regulatory Filings
2026
Mar 17
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19